Ethics and the exchange and commercialisation of products derived from human tissue - background and issues

Summary information

Publishing date: 
2011
Status: 
Rescinded
Reference number: 
e103
Available in print: 
No - PDF only
Further information: 

Note: This publication was revoked by NHMRC in 2017. NHMRC has made this publication available on its internet archives site as a service to the public for information purposes only.

The NHMRC’s Australian Health Ethics Committee (AHEC) has developed a Background and Issues Paper called Ethics and the exchange and commercialisation of products derived from human tissue. The 2007 NHMRC guidelines on organ and tissue donation noted that there was a need for continuing community debate and regulatory oversight over commercialism in tissue banking. The matter was subsequently referred to AHEC to consider the ethical issues. The paper notes that products derived from human tissue are already being processed, exchanged and sometimes traded in Australia. While these products have the potential to deliver significant benefits to human health, this paper highlights ethical aspects that may be applied to their commercialisation.

Related information: 

For more information please contact ethics@nhmrc.gov.au.